InvestorsHub Logo

Steady_T

12/01/18 1:24 PM

#173449 RE: tredenwater2 #173441

Please understand that the biomarker that AVXL is using is not for the AD disease, it is for the effectiveness of 2-73. Those are not the same things.

I have seen nothing that indicates that the biomarkers Anavex has identified can be used in AD disease diagnosis or progression.